MANAGEMENT

Richard H. Smith, CEO and Management Committee Member, has worked since the 1970s in various aspects of science and technology development including strategic planning stints at AT&T, System Development Corporation, and SONY. He was CEO of an artificial intelligence R&D start-up. In recent years, he has been a Research Administrator at Georgetown University Medical School, a professional futurist and long-range strategic planner, and a developer of advanced technology intellectual property from universities in the United States and abroad.

Prof. John F. Currie, Ph.D., Inventor and Management Committee Member, is a Georgetown Professor of Physics and consultant to Walter Reed Army Medical Center. John was the founder of the Georgetown Advanced Electronics Laboratory and a Health Microsystems Research Group Visiting Scientist for Resuscitative Medicine at the Walter Reed Army Institute of Research in Silver Spring, MD.

Andrew McCandlish, Ph.D., Director of Strategic Planning & Business Development, received his Ph.D. in molecular biology from Princeton University. There he identified and characterized novel components of bacterial endotoxin biogenesis in the laboratory of Thomas J. Silhavy. Prior to that, he studied cell signaling and development at The Ohio State University where he also completed the Capital Program in Business Marketing at Fisher College of Business.

MANAGEMENT COMMITTEE

Peter S. Benton, MBA, Management Committee Chair, is a life sciences specialist who has been a Vice President of J&J Pharmaceuticals, a mergers and acquisitions professional at TRW, and an operations professional at General Electric, and Chief Operating Officer of eTrials [NASDAQ:ETWC], a clinical software and services company dedicated to enabling its partners—pharmaceutical, biotechnology and contract research organizations—to bring new drugs to market faster and more efficiently. He is the President of Phoenix Data Systems, a division of Bio-Imaging Technologies, Inc. [NASDAQ:BITI], a leading global clinical data services provider of electronic data capture (“EDC”) services for the electronic clinical trials industry.

Paul A. Brown, M.D., Lead Independent Management Committee Member, is Chairman Emeritus of HearUSA Inc. which he founded in 1986 and for which he served as CEO until 2002 and Chairman of the Board until 2007. He holds an A.B. from Harvard College and an M.D. from Tufts University School of Medicine. From 1970 to 1984, Dr. Brown was Chairman of the Board and CEO of MetPath Inc., now Quest Diagnostics. By 1975 MetPath had one of the best equipped and largest medical laboratories in the world and was the largest U.S. company devoted entirely to clinical laboratory services. It was offering more than 600 laboratory tests to physicians, hospitals, and institutions and performing more than two million lab tests a month from specimens of more than 150,000 patients. Dr. Brown is currently on the faculty and the Visiting Committee of the Columbia University College of Physicians and Surgeons.

Richard S. Press, MBA, Independent Management Committee Member, is the Lead Director of Transatlantic Holdings, Inc., a NYSE listed reinsurance company, and a member of the Investment Committee of Controlled Risk Insurance Company, a medical liability company.  He also is Chairman of the Board of Pomeroy IT Solutions, a NASDAQ company. Dick is on the Board of Governors of Beth Israel Deaconess Hospital in Boston and is a founding and current board member of the Pediatric Multiple Sclerosis Center at SUNY Stony Brook. In addition, he serves as an advisor to the CEO of Standish Mellon, a Boston based asset manager, and as an advisor to The Family Office, a Bahrain wealth management company. Dick previously served as Senior Vice President and Director of the Insurance Asset Management Group of Wellington Management Company and before that Senior Vice President and Director of Insurance Asset Management at Stein, Roe & Farnham and Vice President of Scudder Stevens & Clark.

Michael Patipa, M.D., Independent Managing Committee Member and Chairman of the Scientific Advisory Board, is the founder of Oculoplastic and Orbital Consultants of West Palm Beach, Florida. In addition to his practice and teaching responsibilities, Dr. Patipa operates MBP, LLC which specializes in exporting healthcare and related technology products. Mike founded Permark Corporation, a medical technology company serving the plastic surgery community and Northpoint Outpatient Surgery and Laser Center in West Palm Beach, Florida. He served as a founding board member of Seisint, Inc. of Boca Raton, Florida.

ADVISORS

LTG Ronald R. Blanck, USA (Ret.), DO, Scientific Advisory Board, is Vice Chairman in of Martin, Blanck & Associates. Prior to joining Martin-Blanck, Dr. Blanck served as President of the University of North Texas Health Science Center at Fort Worth. Blanck began his military career in 1968 as a medical officer and battalion surgeon in Vietnam. He retired 32 years later as a Lieutenant General and Surgeon General of the U.S. Army and commander of the U.S. Army Medical Command -- with more than 46,000 military personnel and 26,000 civilian employees throughout the world. During his distinguished military career, Dr. Blanck also served as commander of Walter Reed Medical Center North Atlantic Region Medical Command and director of professional services and chief of Medical Corps Affairs for the U.S. Army Surgeon General. Other assignments included assistant chief of the General Medicine Service in the Department of Medicine at Walter Reed, assistant dean of student affairs at the Uniformed Services University School of Medicine and chief of the Department of Medicine at Brooke Army Medical Center.

Reuben Mezrich, M.D., Ph.D., Scientific Advisory Board, is the Chairman of the Department of Diagnostic Radiology and Nuclear Medicine at the University of Maryland’s School of Medicine. Prior to going to medical school, Dr. Mezrich worked as an electrical engineer at Johnson & Johnson and had a key role in the development of ultrasound mammography systems to detect breast cancer. Dr. Mezrich holds 25 patents.

Jay H. Sanders, M.D., Scientific Advisory Board, is President and CEO of The Global Telemedicine Group, Professor of Medicine at Johns Hopkins University School of Medicine (Adjunct), and a founding board member of the American Telemedicine Association where he serves as President Emeritus. He is a consultant to the Army’s Telemedicine and Advanced Technology Research Center (TATRC) at Ft. Detrick, as well as to the CIO of the Military Health System, and previously to the Defense Advanced Research Projects Agency (DARPA), and served as a consultant to the Air Force Center for Telehealth and Theater Informatics, and was a member of the Department of Defense Telemedicine Board of Directors with the Surgeon Generals of the Army, Navy, and Air Force.  He is a consultant to Vesalius Ventures, a Venture Capital Firm focusing on telehealth, medical informatics, and medical sensors, and was a consultant to Columbia University School of Medicine and their Center for Advanced Technology, and was formerly Visiting Professor at Yale University School of Medicine and Professor of Medicine and Surgery and Director of the Telemedicine Program at the Medical College of Georgia, where he held the Eminent Scholar Chair in Telemedicine.

Bergitta Smith, FACMPE, Scientific Advisory Board, is the Executive Vice President of the Alliance for Academic Internal Medicine, a division of the Association of American Medical Colleges. She has been the Chief Operating Officer of the National Patient Safety Foundation, the Assistant Executive Director of the American Society of Plastic Surgeons, the Director of Medical Staff Affairs at the Philadelphia Children’s Hospital, and Executive Director of the Retina Service of Wills Eye Hospital. She has also served as the Chairman of the Board of the Medical Group Management Association and chaired its Finance and Audit and Investment Committees.

Neal Walker, M.D., Scientific Advisory Board, is co-founder of Octagon Research Solutions. He is a Board-certified practicing dermatologist with nearly 10 years of experience as a consultant to the pharmaceutical industry. Neal has worked as a medical consultant for Johnson & Johnson, AstraMerck and AstraZeneca. Additionally, he has served on the Advisory committee safety team for the “Prescription to OTC” switch of Prilosec®.

Les Wold, M.D., Scientific Advisory Board, is JARI Research Corporation's Chief Medical Director. Dr. Wold assumed this position in July 2006. As chief medical director, Dr. Wold plans and directs all aspects of JARI's medical policies and programs. He is responsible for strategic clinical relationships with physicians and health care providers. He ensures all clinical programs align with JARI's goals and priorities. Before joining JARI, Les had a distinguished 25-year career with the Mayo Clinic. Most recently he was professor of pathology at the Mayo Clinic College of Medicine and emeritus chair of the Department of Laboratory Medicine and Pathology.

Stanley Alterman, Ph.D., Special Consultant for Government Relations, has more than thirty years experience in the Defense industry, both in government and private sectors. During the Reagan administration he served as Assistant Deputy Undersecretary of Defense. After leaving government service, Dr. Alterman founded Alterman Associates Inc., a defense consulting firm. He has served as a member of and/or consultant to the Defense Science Board, the Air Force Science Advisory Board, the ASD Division Advisory Group of Argonne National Labs, the Air Force Director of Test and Evaluation, the FAA, the Air Force Space Command and a consultant to defense industry firms including Lockheed Martin, L-3 Communications, and ITT. Prior to his term in the Pentagon, Stan worked at Raytheon Corporation where he was Executive Vice President of the New Jersey Electronic Warfare Operation. Prior to this he was Director of Electronic Warfare and Development at ITT Avionics Division.